Copyright
©The Author(s) 2025.
World J Gastroenterol. Apr 14, 2025; 31(14): 105004
Published online Apr 14, 2025. doi: 10.3748/wjg.v31.i14.105004
Published online Apr 14, 2025. doi: 10.3748/wjg.v31.i14.105004
Figure 1 Flow diagram of the population enrolled.
The experimental design flow of this study, including the steps of sample collection, grouping and treatment. Each box represents a stage of the experiment, and the arrows indicate the direction of the process. ACLF: Acute-on-chronic liver failure; TCP: Thrombocytopenia; TPO: Thrombopoietin.
- Citation: Liu G, Tang F, Wang T, Yan JQ, Li FH, Ha FS, Zhang X, Jing L, Liang J. Efficacy of recombinant human thrombopoietin in patients with acute-on-chronic liver failure and thrombocytopenia: A prospective, open-label study. World J Gastroenterol 2025; 31(14): 105004
- URL: https://www.wjgnet.com/1007-9327/full/v31/i14/105004.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i14.105004